Cormorant Asset Management LP 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 3:03 pm Sale |
2024-09-30 | 13G | CytomX Therapeutics, Inc. CTMX |
Cormorant Asset Management LP | 0 0.000% |
-5,750,000 (Position Closed) |
Filing |
| 2024-05-13 4:00 pm Purchase |
2024-05-02 | 13G | CytomX Therapeutics, Inc. CTMX |
Cormorant Asset Management LP | 5,750,000 7.380% |
5,750,000 (New Position) |
Filing |